YOLFTbeta
BioLife Solutions Inc

BioLife Solutions Inc

BLFS · NASDAQ · Healthcare / Medical Instruments & Supplies

38.61USD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close38.61
Open38.61
Day Range38.61 – 38.61
52-Week Range17.86 – 38.89
Volume0
Market Cap1.89B
P/E (TTM)37.82
Forward P/E238.10
EPS1.02
Dividend Yield0.00%
Beta1.92
50-Day Avg34.52
200-Day Avg26.14

About

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction products, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; CryoCase cryo-compatible transparent rigid containers for closed-system fill and retrieval, and automated cell processing machines; and the ThawSTAR line include automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Roderick de Greef
  • Employees155
  • Headquarters3303 Monte Villa Parkway, Bothell, WA, United States, 98021, USA
  • Websitehttps://www.biolifesolutions.com

Leadership

  • Mr. Roderick de GreefCEO & Chairman · b. 1960
  • Mr. Sean Werner Ph.D.Chief Technology Officer · b. 1974
  • Dr. Aby J. Mathew Ph.D.Chairman of Scientific Advisory Board, Executive VP & Chief Scientific Officer · b. 1972
  • Mr. Todd BerardChief Commercial Officer · b. 1969

Financials

Income Statement

Currency: USD1988-12-311989-12-311990-12-311991-12-311992-12-311993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue100.00K100.00K100.00K100.00K5.90M13.40M13.59M13.59M13.59M3.57M2.37M1.78M1.19M422.27K848.79K605.51K626.71K614.72K603.22K972.26K1.32M1.58M2.08M2.76M5.66M8.95M6.19M6.45M8.23M11.02M19.74M27.37M48.09M119.16M76.24M68.02M82.25M96.21M
Growth (%)-0.00%0.00%0.00%+5800.00%+127.12%+1.45%0.00%0.00%-73.73%-33.65%-25.03%-33.04%-64.50%+101.01%-28.66%+3.50%-1.91%-1.87%+61.18%+36.02%+19.59%+31.61%+32.53%+105.28%+58.03%-30.83%+4.17%+27.57%+33.97%+79.11%+38.64%+75.69%+147.79%-36.02%-10.79%+20.93%+16.97%
Cost of Revenue200.00K800.00K1.20M2.70M4.70M6.80M5.76M5.76M5.76M1.92M1.28M680.72K268.96K788.70K1.43M109.39K163.98K250.08K298.06K463.11K770.65K1.01M1.23M1.36M3.37M5.19M3.16M2.63M3.45M4.28M6.22M9.84M23.68M82.11M29.33M26.70M28.58M34.10M
Gross Profit-100.00K-700.00K-1.10M-2.60M1.20M6.60M7.83M7.83M7.83M1.65M1.09M1.10M920.55K555.32K848.79K496.12K462.73K364.64K305.15K509.16K551.85K574.58K856.39K1.40M2.29M3.76M3.04M3.81M4.78M6.75M13.53M17.53M24.41M37.05M46.91M41.32M53.67M62.12M
Gross Margin-100.00%-700.00%-1100.00%-2600.00%20.34%49.25%57.61%57.61%57.61%46.28%46.15%61.68%77.39%131.51%100.00%81.93%73.83%59.32%50.59%52.37%41.73%36.33%41.14%50.86%40.48%42.05%49.03%59.15%58.09%61.20%68.51%64.05%50.76%31.09%61.53%60.75%65.25%64.56%
Operating Expense200.00K2.00M3.90M4.20M3.90M8.41M9.64M9.64M11.25M3.31M2.34M2.24M3.79M833.35K1.47M1.89M1.12M992.17K1.80M3.22M3.02M2.86M2.25M2.61M3.23M4.05M6.17M8.83M9.63M7.80M9.86M17.75M27.74M67.70M52.83M60.72M60.80M63.20M
Operating Income-300.00K-2.70M-5.00M-6.80M-2.70M-1.81M-1.81M-1.81M-3.41M-1.66M-1.24M-1.14M-2.87M-278.03K-620.11K-1.39M-658.42K-627.53K-1.49M-2.71M-2.46M-2.29M-1.39M-1.21M-942.24K-285.36K-3.14M-5.02M-4.85M-1.06M3.66M-220.00K-3.33M-30.65M-5.92M-19.40M-7.13M-1.08M
Operating Margin-300.00%-2700.00%-5000.00%-6800.00%-45.76%-13.52%-13.33%-13.33%-25.12%-46.40%-52.47%-64.45%-241.28%-65.84%-73.06%-229.80%-105.06%-102.08%-247.73%-279.09%-186.27%-144.62%-66.98%-43.85%-16.64%-3.19%-50.65%-77.80%-58.96%-9.58%18.55%-0.80%-6.93%-25.72%-7.77%-28.52%-8.67%-1.12%
EBITDA-300.00K-2.50M-4.70M-6.70M-2.40M-1.39M-1.80M-1.39M-3.02M-1.24M-901.24K-861.17K-2.60M-266.65K-451.23K-1.14M-492.22K-561.45K-1.44M-2.68M-2.43M-2.19M-1.32M-1.11M-772.59K-38.28K-2.88M-4.67M-7.35M-717.32K4.00M2.57M2.47M-17.78M-3.10M-7.10M1.53M3.61M
EBITDA Margin-300.00%-2500.00%-4700.00%-6700.00%-40.68%-10.34%-13.28%-10.19%-22.19%-34.61%-38.03%-48.47%-218.90%-63.15%-53.16%-188.25%-78.54%-91.33%-239.48%-275.32%-184.06%-138.26%-63.60%-40.39%-13.64%-0.43%-46.48%-72.48%-89.40%-6.51%20.26%9.38%5.14%-14.92%-4.06%-10.44%1.86%3.75%
Net Income-500.00K-2.60M-4.70M-6.60M-2.60M-2.23M-2.23M-2.23M-3.40M-1.59M-1.27M-1.18M-2.77M-4.41M215.88K-1.30M-743.16K-619.32K-1.13M-2.85M-2.78M-2.77M-1.98M-1.96M-1.66M-1.08M-3.22M-4.21M-6.88M-2.52M3.27M-1.66M2.67M-8.91M-139.81M-68.00M-20.18M-12.13M
Net Income Margin-500.00%-2600.00%-4700.00%-6600.00%-44.07%-16.65%-16.41%-16.41%-25.04%-44.52%-53.52%-66.18%-233.03%-1044.41%25.43%-215.25%-118.58%-100.75%-187.99%-293.31%-209.84%-175.03%-95.30%-70.93%-29.31%-12.11%-51.98%-65.34%-83.57%-22.82%16.54%-6.05%5.55%-7.48%-183.38%-99.98%-24.54%-12.61%
R&D-----2.90M2.90M2.90M2.90M1.29M674.16K687.45K1.37M1.77M644.80K759.31K29.09K27.86K57.33K413.38K457.64K414.46K318.90K516.45K463.64K487.82K871.10K1.38M2.03M1.19M1.30M4.12M6.72M11.82M14.80M5.51M7.91M7.57M
R&D as % of Total Revenue-----21.64%21.33%21.33%21.33%36.22%28.45%38.70%115.47%419.90%75.97%125.40%4.64%4.53%9.50%42.52%34.60%26.21%15.32%18.72%8.19%5.45%14.07%21.38%24.66%10.82%6.57%15.05%13.97%9.92%19.41%8.11%9.62%7.86%
Interest Expense0200.00K200.00K0200.00K000070.00K30.00K30.82K00506.38K52.31K117.24K1.94K56.54K138.28K284.76K488.01K588.00K745.39K811.97K798.80K177.31K21.75K318.39K190.07K5.00K5.00K18.00K485.00K687.00K1.81M719.00K2.71M
Interest Expense % of Total Revenue0.00%200.00%200.00%0.00%3.39%0.00%0.00%0.00%0.00%1.96%1.27%1.73%0.00%0.00%59.66%8.64%18.71%0.32%9.37%14.22%21.53%30.86%28.25%27.02%14.34%8.93%2.86%0.34%3.87%1.72%0.03%0.02%0.04%0.41%0.90%2.66%0.87%2.81%

Balance Sheet

Currency: USD1988-12-311989-12-311990-12-311991-12-311992-12-311993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets500.00K3.50M5.60M13.00M8.40M9.10M8.40M8.40M6.04M3.88M2.73M2.16M3.99M1.78M313.85K2.96M833.27K447.11K560.43K726.02K1.17M1.33M1.31M1.66M3.17M3.35M16.07M12.37M7.93M12.14M45.47M93.01M234.83M554.29M450.23M412.71M399.49M405.88M
Total Liabilities400.00K200.00K100.00K1.20M2.80M3.80M4.42M4.42M2.05M1.42M1.30M1.34M360.26K1.47M868.10K1.61M220.31K408.62K380.34K3.20M6.34M9.16M10.86M12.84M15.66M16.62M2.14M2.51M4.76M2.05M30.84M49.36M29.58M76.24M86.04M75.05M50.58M34.00M
Total Equity100.00K3.30M5.50M12.00M5.60M5.30M3.98M3.98M3.99M2.46M1.43M818.40K3.63M310.77K-554.25K1.36M612.96K38.48K180.09K-2.47M-5.17M-7.83M-9.55M-11.18M-12.49M-13.27M11.80M8.51M3.17M10.09M14.63M83.03M205.25M478.05M364.19M337.66M348.91M371.89M
Cash400.00K2.30M5.20M2.30M2.00M1.12M1.12M1.12M1.77M124.00K135.18K7.95K2.15M286.11K67.12K787.90K531.68K185.09K118.67K56.50K98.72K139.15K3.21K16.86K196.48K156.27K2.54M3.82M1.41M6.66M30.66M6.45M90.46M69.86M19.44M27.90M95.39M33.04M
Total Debt---100.00K-53.74K53.74K53.74K22.66K177.92K127.30K180.66K10.86K-345.82K705.52K-225.93K197.48K2.75M5.06M7.89M9.03M10.13M10.60M10.60M121.87M-5.69M--1.37M11.15M26.88M43.71M33.83M30.17M17.90M
Net Debt-400.00K-2.30M-5.20M-2.20M-2.00M-1.06M-1.06M-1.06M-1.77M53.92K-7.88K172.71K-2.14M-286.11K278.71K-82.38K-531.68K40.83K78.80K2.69M4.96M7.75M9.03M10.11M10.41M10.45M-9.94M-3.82M1.44M-6.66M-30.66M-5.08M-79.30M-42.98M24.27M5.93M-65.21M-15.14M

Cash Flow

Currency: USD1989-12-311990-12-311991-12-311992-12-311993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-1.30M-2.50M-4.30M-8.40M-2.60M-1.54M-1.54M-2.07M-1.49M29.12K-266.26K-2.90M-2.64M-2.68M-854.23K515.10K-576.33K-712.20K-2.71M-2.11M-2.41M-1.25M-989.92K854.93K146.01K-3.16M-4.97M-4.33M605.00K2.35M1.21M6.51M-4.84M-8.49M-12.50M8.43M20.11M
Investing Cash Flow-1.10M800.00K-9.80M8.00M800.00K--320.13K-65.21K-245.14K-204.69K-382.70K-200.74K-279.33K2.11M-11.22K-65.80K3.82K-35.55K-105.55K-46.69K-373.53K-28.41K-91.43K-1.15M-236.67K-8.14M4.24M393.00K-144.00K-6.50M-27.02M-23.73M-12.64M-58.12M17.84M58.30M-71.54M
Financing Cash Flow4.30M4.60M11.10M100.00K2.30M553.28K553.28K2.27M94.82K186.76K521.73K5.24M1.06M345.82K1.59M-705.52K225.93K681.33K2.75M2.20M2.83M1.15M1.09M475.00K50.46K13.68M368.75K3.17M4.80M28.15M1.60M102.08M-2.78M16.32M10.59M-6.78M-10.92M
Capital Expenditure0100.00K400.00K900.00K200.00K317.24K317.24K60.45K355.29K249.62K220.00K185.74K279.33K87.39K11.22K65.80K15.11K35.55K105.55K46.69K373.53K28.41K93.53K1.15M236.67K589.68K1.42M1.26M143.77K500.00K675.00K4.63M8.38M10.38M6.38M3.23M19.70M
Free Cash Flow-1.30M-2.60M-4.70M-9.30M-2.80M-1.86M-1.86M-2.13M-1.85M-220.50K-266.26K-3.08M-2.92M-2.76M-865.45K449.30K-591.44K-747.75K-2.81M-2.16M-2.79M-1.28M-1.08M-296.79K-90.66K-3.75M-6.39M-5.58M461.23K1.85M538.00K1.88M-13.22M-18.87M-18.88M5.20M416.00K
Dividends Paid----------------------000106.25K106.00K106.00K106.25K436.00K0------
FCF to OCF100.00%104.00%109.30%110.71%107.69%120.57%120.57%102.92%123.77%-757.27%100.00%106.41%110.57%103.26%101.31%87.23%102.62%104.99%103.90%102.21%115.48%102.27%109.45%-34.71%-62.09%118.65%128.50%129.05%76.24%78.71%44.35%28.89%273.39%222.33%151.06%61.72%2.07%
Dividend Paid to FCF----------------------0.00%0.00%0.00%-2.83%-1.66%-1.90%23.04%23.59%0.00%------

Earnings

Report DateMar 31, 1998Jun 30, 1998Sep 30, 1998Dec 31, 1998Mar 31, 1999Jun 30, 1999Sep 30, 1999Dec 31, 1999Mar 31, 2000Jun 30, 2000Sep 30, 2000Dec 31, 2000Mar 31, 2001Jun 30, 2001Sep 30, 2001Dec 31, 2001Mar 31, 2002Jun 30, 2002Sep 30, 2002Dec 31, 2002Mar 31, 2003Jun 30, 2003Sep 30, 2003Dec 31, 2003Mar 31, 2004Jun 30, 2004Sep 30, 2004Dec 31, 2004Mar 31, 2005Jun 30, 2005Sep 30, 2005Dec 31, 2005Mar 31, 2006Jun 30, 2006Sep 30, 2006Dec 31, 2006Mar 31, 2007Jun 30, 2007Sep 30, 2007Dec 31, 2007Mar 31, 2008Jun 30, 2008Sep 30, 2008Dec 31, 2008Mar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Aug 14, 2012Nov 13, 2012Dec 31, 2012May 14, 2013Aug 12, 2013Nov 14, 2013Feb 12, 2014May 8, 2014Aug 7, 2014Nov 6, 2014Mar 12, 2015May 7, 2015Aug 6, 2015Nov 12, 2015Feb 25, 2016May 12, 2016Aug 11, 2016Nov 10, 2016Mar 9, 2017May 11, 2017Aug 10, 2017Nov 9, 2017Mar 8, 2018May 10, 2018Aug 9, 2018Nov 8, 2018Mar 14, 2019May 9, 2019Aug 8, 2019Nov 12, 2019Mar 11, 2020May 14, 2020Aug 6, 2020Nov 5, 2020Mar 22, 2021May 13, 2021Aug 12, 2021Nov 11, 2021Feb 28, 2022May 9, 2022Aug 9, 2022Nov 9, 2022Mar 16, 2023May 10, 2023Aug 8, 2023Nov 9, 2023Feb 29, 2024May 9, 2024Aug 8, 2024Nov 12, 2024Feb 26, 2025May 8, 2025Aug 7, 2025Nov 6, 2025Feb 26, 2026May 7, 2026Aug 6, 2026Nov 5, 2026
EPS Estimate----------------------------------------------------------0.14-0.14---0.14-0.14-0.07-0.04-0.04-0.06-0.07-0.09-0.09-0.11-0.11-0.08-0.08-0.08-0.07-0.05-0.04-0.05-0.040.020.050.070.050.060.050.02-0.020.02-0.04-0.01-0.02-0.040.03-0.09-0.17-0.17-0.15-0.10-0.17-0.16-0.18-0.28-0.27-0.28-0.09-0.05-0.06-0.04-0.02-0.01-0.020.02-0.010.01
EPS Actual-1.39-0.31-0.21-0.75-0.65-0.18-0.38-1.23-0.32-1.46-0.78-1.23-1.21-1.55-1.28-0.94-0.431.30-0.34-0.33-0.38-0.56-0.640.12-0.29-0.26-0.17-0.14-0.18-0.21-0.18-0.14-0.24-0.11-0.08-0.01-0.12-0.15-0.15-0.14-0.13-0.13-0.13-0.16-0.17-0.20-0.11-0.07-0.11-0.11-0.09-0.09-0.13-0.09-0.10-0.08-0.06-0.14-0.14-0.10-0.00-0.06-0.06-0.21-0.10-0.07-0.07-0.08-0.09-0.08-0.09-0.09-0.10-0.11-0.08-0.26-0.05-0.04-0.02-0.05-0.010.060.070.040.050.040.010.020.06-0.01-0.02-0.060.01-0.12-0.19-0.37-0.19-0.13-0.15-1.15-0.27-0.24-0.34-0.21-0.23-0.05-0.02-0.020.04-0.330.040.040.040.04-
Surprise---------------------------------------------------------0.00%0.00%--59.64%55.79%-200.00%-150.00%-75.00%-16.67%-14.29%0.00%11.11%18.18%18.18%-25.00%-37.50%0.00%-271.43%0.00%0.00%60.00%-25.00%-150.00%20.00%0.00%-20.00%-16.67%-20.00%-50.00%200.00%200.00%75.00%-100.00%-200.00%125.00%-500.00%-111.11%-117.65%-11.76%13.33%-50.00%-576.47%-68.75%-33.33%-21.43%22.22%17.86%44.44%60.00%71.78%200.00%-1550.00%453.98%300.00%100.00%500.00%-
Timing---------------------------------------------------------Pre-marketPre-market-Pre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap1.89B
Enterprise Value1.78B
Trailing P/E37.82
Forward P/E238.10
PEG Ratio65.38
Price / Sales17.69
Price / Book4.39
EPS1.02
Book Value8.59
Revenue (TTM)106.69M
Gross Profit (TTM)67.87M
EBITDA6.90M
Profit Margin54.35%
Operating Margin5.96%
Return on Equity12.83%
Return on Assets0.26%
Shares Outstanding48.92M
Shares Float42.84M
Beta1.92
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 9 analystsTarget 31.29
  • Strong Buy
    7
  • Buy
    2

Ownership Breakdown

Institutions
105.67%
Insiders
2.62%
Retail / Other
0.00%

Top Institutional Holders

  • T. Rowe Price Investment Management,Inc.
    6.51M13.30%
  • BlackRock Inc
    6.10M12.47%
  • Casdin Capital, LLC
    4.66M9.51%
  • Amvescap Plc.
    2.35M4.80%
  • Vanguard Capital Management, LLC
    1.92M3.92%
  • State Street Corp
    1.58M3.22%
  • FMR Inc
    1.47M3.01%
  • Massachusetts Financial Services Company
    1.20M2.45%
  • Fred Alger Management, LLC
    1.08M2.21%
  • Dimensional Fund Advisors, Inc.
    1.05M2.14%
  • Geode Capital Management, LLC
    971.93K1.99%
  • Bank of America Corp
    904.10K1.85%
  • Ameriprise Financial Inc
    901.14K1.84%
  • Royal Bank of Canada
    885.30K1.81%

Top Fund Holders

  • T. Rowe Price Small-Cap Stock
    2.46M5.03%
  • iShares Core S&P Small-Cap ETF
    2.41M4.93%
  • Vanguard MStar Total Stk Mkt Idx Invest
    1.46M2.99%
  • T. Rowe Price Instl Small-Cap Stock
    1.33M2.71%
  • iShares Russell 2000 ETF
    1.08M2.21%
  • Alger Small Cap Focus I
    1.02M2.09%

Stock Splits

  • Jan 29, 20141:14
  • Jun 16, 20001:5